Skip to Content

Hydrochlorothiazide / methyldopa Pregnancy and Breastfeeding Warnings

Hydrochlorothiazide / methyldopa is also known as: Aldoril, Aldoril 15, Aldoril 25, Aldoril D30, Aldoril D50

Hydrochlorothiazide / methyldopa Pregnancy Warnings

Animal studies have failed to reveal evidence of fetal harm. In humans, treatment with methyldopa has revealed improved fetal outcome as well as reduced infant average head circumference (0.4 cm). There are no controlled data in the first trimester of human pregnancy; there are no controlled data for hydrochlorothiazide in the second and third trimesters. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if clearly needed. US FDA pregnancy category: C

See references

Hydrochlorothiazide / methyldopa Breastfeeding Warnings

A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Yes (hydrochlorothiazide, methyldopa [in small amounts]) Comments: According to some experts, the individual components of this drug can be used safely during lactation; hydrochlorothiazide 50 mg per day or less is considered acceptable during lactation while no special precautions are required for methyldopa.

See references

References for pregnancy information

  1. "Product Information. Aldoril (methyldopa-hydrochlorothiazide)." Merck & Co, Inc, West Point, PA.

References for breastfeeding information

  1. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):
  2. "Product Information. Aldoril (methyldopa-hydrochlorothiazide)." Merck & Co, Inc, West Point, PA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.